Expertise in
18
conditions

Francesco Ferrau

Messina, IT 
Expertise in
18
conditions
Messina, IT 

Overview

Francesco Ferrau practices practicing medicine in Messina, Italy.

Mr. Ferrau is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, and Gallbladder Removal.

He is actively involved in clinical research, co-authoring 175 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Messina, Italy
Other Locations
Taormina, 98039, Italy
Brindisi, Italy
Benevento, 82100, Italy
Cannizzaro, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Enrollment Status: Terminated
Publish Date: October 09, 2019
Intervention Type: Drug
Study Phase: Phase 3
Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial
Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial
Enrollment Status: Completed
Publish Date: April 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

175 Total Publications

Safety and effectiveness of setmelanotide in young patients with severe obesity due to craniopharyngioma: a real world monocentric experience.
Safety and effectiveness of setmelanotide in young patients with severe obesity due to craniopharyngioma: a real world monocentric experience.
Journal: Journal of endocrinological investigation
Published: March 13, 2026

Frequently Asked Questions about Francesco Ferrau

Is Francesco Ferrau a top-rated expert for Pituitary Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Francesco Ferrau is classified as an Elite expert for Pituitary Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Francesco Ferrau participate in research or clinical trials?

Yes. Francesco Ferrau has published 175 articles and abstracts on conditions like Pituitary Tumor. You can view a list of Francesco Ferrau's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ferrau's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile